David Owens's most recent trade in Hillman Solutions Corp was a trade of 18,893 Common Stock done . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hillman Solutions Corp | David A. Owens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,893 | 64,704 | - | 0 | Common Stock | |
| Nexalin Technology Inc | David Owens | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 654,363 | 794,184 | - | - | Stock Option (right to buy) | |
| Nexalin Technology Inc | David Owens | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 139,821 | 139,821 | - | - | Stock Option (right to buy) | |
| Nexalin Technology Inc | David Owens | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 125,000 | 919,184 | - | - | Stock Option (right to buy) | |
| Nexalin Technology Inc | David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.98 per share. | 04 Feb 2025 | 1,000 | 154,793 | - | 3.0 | 2,980 | Common stock |
| Nexalin Technology Inc | David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 3.10 per share. | 04 Feb 2025 | 1,000 | 155,793 | - | 3.1 | 3,100 | Common stock |
| Nexalin Technology Inc | David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.70 per share. | 28 Jan 2025 | 1,500 | 153,793 | - | 2.7 | 4,050 | Common stock |
| Nexalin Technology Inc | David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.50 per share. | 13 Jan 2025 | 2,000 | 151,293 | - | 2.5 | 5,000 | Common stock |
| Nexalin Technology Inc | David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.70 per share. | 13 Jan 2025 | 1,000 | 152,293 | - | 2.7 | 2,700 | Common stock |
| Nexalin Technology Inc | David Owens | Director, Chief Medical Officer | 31 Dec 2024 | 262,500 | 262,500 | - | - | Stock Option (right to buy) | ||
| Nexalin Technology Inc | David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 31 Dec 2024 | 1,000 | 149,293 | - | 2.8 | 2,750 | Common stock |
| Nexalin Technology Inc | David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.19 per share. | 28 Oct 2024 | 500 | 148,293 | - | 2.2 | 1,095 | Common stock |
| Nexalin Technology Inc | David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 13 Aug 2024 | 1,000 | 147,793 | - | 1.0 | 950 | Common stock |
| Nexalin Technology Inc | David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.75 per share. | 28 Jun 2024 | 1,000 | 146,793 | - | 1.8 | 1,750 | Common stock |
| Nexalin Technology Inc | David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.71 per share. | 18 Jun 2024 | 1,619 | 145,793 | - | 0.7 | 1,149 | Common stock |
| Nexalin Technology Inc | David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.65 per share. | 10 Jun 2024 | 2,000 | 143,174 | - | 0.7 | 1,300 | Common stock |
| Nexalin Technology Inc | David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.62 per share. | 10 Jun 2024 | 1,000 | 144,174 | - | 0.6 | 620 | Common stock |
| Hillman Solutions Corp | David A. Owens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 13,605 | 45,811 | - | 0 | Common Stock | |
| Hillman Solutions Corp | David A. Owens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 14,669 | 32,206 | - | 0 | Common Stock | |
| Nexalin Technology Inc | David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 4.15 per share. | 16 Sep 2022 | 2,500 | 141,174 | - | 4.2 | 10,375 | Common Stock |
| Nexalin Technology Inc | David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Sep 2022 | 2,500 | 2,500 | - | - | Common stock warrants | |
| Hillman Solutions Corp | David A. Owens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 10,330 | 17,537 | - | 0 | Common Stock | |
| Hillman Solutions Corp | David Owens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 7,207 | 7,207 | - | 0 | Common Stock |